Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Aurinia Pharmaceuticals Inc Cash on Hand 2014-2023 | AUPH

Aurinia Pharmaceuticals Inc cash on hand from 2014 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Aurinia Pharmaceuticals Inc Annual Cash on Hand
(Millions of US $)
2023 $350
2022 $389
2021 $466
2020 $398
2019 $306
2018 $126
2017 $173
2016 $40
2015 $16
2014 $33
2013 $
Aurinia Pharmaceuticals Inc Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $350
2023-09-30 $338
2023-06-30 $351
2023-03-31 $362
2022-12-31 $389
2022-09-30 $377
2022-06-30 $392
2022-03-31 $419
2021-12-31 $466
2021-09-30 $286
2021-06-30 $319
2021-03-31 $348
2020-12-31 $398
2020-09-30 $392
2020-06-30 $264
2020-03-31 $286
2019-12-31 $306
2019-09-30 $135
2019-06-30 $131
2019-03-31 $144
2018-12-31 $126
2018-09-30 $139
2018-06-30 $150
2018-03-31 $159
2017-12-31 $173
2017-09-30 $182
2017-06-30 $190
2017-03-31 $202
2016-12-31 $40
2016-09-30 $15
2016-06-30 $12
2016-03-31 $11
2015-12-31 $16
2015-09-30 $21
2015-06-30 $26
2015-03-31 $29
2014-12-31 $33
2014-09-30 $36
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.696B $0.176B
Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.026B 28.78
Chugai Pharmaceutical (CHGCY) Japan $53.561B 23.26
Takeda Pharmaceutical (TAK) Japan $41.649B 6.75
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Shionogi (SGIOY) Japan $14.066B 12.17
Sandoz Group AG (SDZNY) Switzerland $13.508B 0.00
Neurocrine Biosciences (NBIX) United States $13.189B 54.77
United Therapeutics (UTHR) United States $11.150B 11.94
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.652B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.884B 6.98
Ionis Pharmaceuticals (IONS) United States $5.948B 0.00
Revolution Medicines (RVMD) United States $5.901B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.422B 0.00
Alpine Immune Sciences (ALPN) United States $4.223B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.994B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 0.00
Indivior (INDV) United States $2.587B 12.03
Evotec AG (EVO) Germany $2.534B 0.00
Summit Therapeutics (SMMT) United States $2.463B 0.00
Corcept Therapeutics (CORT) United States $2.346B 23.85
Dyne Therapeutics (DYN) United States $2.038B 0.00
PTC Therapeutics (PTCT) United States $1.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.810B 18.71
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.736B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.735B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.646B 9.75
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.574B 0.00
Ardelyx (ARDX) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.268B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.190B 11.18
Xencor (XNCR) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.137B 7.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.056B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.928B 0.00
Cronos Group (CRON) Canada $0.921B 0.00
Cassava Sciences (SAVA) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.871B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Enliven Therapeutics (ELVN) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.814B 0.00
Relay Therapeutics (RLAY) United States $0.802B 0.00
Sage Therapeutics (SAGE) United States $0.783B 0.00
Savara (SVRA) United States $0.662B 0.00
Silence Therapeutics (SLN) United Kingdom $0.659B 0.00
Lyell Immunopharma (LYEL) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.585B 8.66
Verve Therapeutics (VERV) United States $0.557B 0.00
ProKidney (PROK) United States $0.550B 0.00
OmniAb (OABI) United States $0.538B 0.00
Korro Bio (KRRO) United States $0.536B 0.00
Exscientia (EXAI) United Kingdom $0.527B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.526B 0.00
Altimmune (ALT) United States $0.488B 0.00
KalVista Pharmaceuticals (KALV) United States $0.485B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.447B 0.00
Heron Therapeutics (HRTX) United States $0.407B 0.00
Larimar Therapeutics (LRMR) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Lexeo Therapeutics (LXEO) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.384B 0.00
Harrow (HROW) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.354B 0.00
Nature's Sunshine Products (NATR) United States $0.352B 19.68
Aquestive Therapeutics (AQST) United States $0.330B 0.00
Lyra Therapeutics (LYRA) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.315B 0.00
ESSA Pharma (EPIX) Canada $0.297B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.293B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.290B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Adherex Technologies (FENC) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.259B 0.00
Xeris Biopharma Holdings (XERS) United States $0.247B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Acrivon Therapeutics (ACRV) United States $0.239B 0.00
Telomir Pharmaceuticals (TELO) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.235B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.218B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Century Therapeutics (IPSC) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Prelude Therapeutics (PRLD) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
MediWound (MDWD) Israel $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.143B 13.35
GlycoMimetics (GLYC) United States $0.139B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Citius Pharmaceuticals (CTXR) United States $0.128B 0.00
Inotiv (NOTV) United States $0.121B 0.00
Eliem Therapeutics (ELYM) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
OptiNose (OPTN) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.072B 5.80
Journey Medical (DERM) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Viracta Therapeutics (VIRX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
JanOne (JAN) United States $0.032B 0.00
Nutriband (NTRB) United States $0.032B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 11.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
CERo Therapeutics Holdings (CERO) United States $0.023B 0.00
Addex Therapeutics (ADXN) Switzerland $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
Indaptus Therapeutics (INDP) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.010B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.19
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.81